A cis-regulatory-directed pipeline for the identification of genes involved in cardiac development and disease
Authors:
- Hieu T. NimHNHieu T. Nim
- Louis DangLDLouis Dang
- Harshini ThiyagarajahHTHarshini Thiyagarajah
- Daniel BakopoulosDBDaniel Bakopoulos
- Michael SeeMSMichael See
- Natalie CharitakisNCNatalie Charitakis
- Tennille SibbrittTSTennille Sibbritt
- Michael P. EichenlaubMEMichael P. Eichenlaub
- Stuart K. ArcherSAStuart K. Archer
- Nicolas FossatNFNicolas Fossat
- Richard E. BurkeRBRichard E. Burke
- Patrick P. L. TamPTPatrick P. L. Tam
Open Access
- 15 December 2021
- journal article
- research article
- Published by Springer Nature in Genome Biology
- Vol. 22 (1) , 1-21
Abstract
Background: Congenital heart diseases are the major cause of death in newborns, but the genetic etiology of this developmental disorder is not fully known. The conventional approach to identify the disease-causing genes focuses on screening genes that display heart-specific expression during development. However, this approach would have discounted genes that are expressed widely in other tissues but may play critical roles in heart development. Results: We report an efficient pipeline of genome-wide gene discovery based on the identification of a cardiac-specific cis-regulatory element signature that points to candidate genes involved in heart development and congenital heart disease. With this pipeline, we retrieve 76% of the known cardiac developmental genes and predict 35 novel genes that previously had no known connectivity to heart development. Functional validation of these novel cardiac genes by RNAi-mediated knockdown of the conserved orthologs in Drosophila cardiac tissue reveals that disrupting the activity of 71% of these genes leads to adult mortality. Among these genes, RpL14, RpS24, and Rpn8 are associated with heart phenotypes. Conclusions: Our pipeline has enabled the discovery of novel genes with roles in heart development. This workflow, which relies on screening for non-coding cis-regulatory signatures, is amenable for identifying developmental and disease genes for an organ without constraining to genes that are expressed exclusively in the organ of interest.Keywords
Funding Information
- Australian Research Council (DP140101067, DP160100933)
- National Health and Medical Research Council (1049980, 1182330)
- National Health and Medical Research Council (1180905)
This publication has 60 references indexed in Scilit:
- An integrated encyclopedia of DNA elements in the human genomeNature, 2012
- A Transcription Factor Collective Defines Cardiac Cell Fate and Reflects Lineage HistoryCell, 2012
- The NIH Roadmap Epigenomics Mapping ConsortiumNature Biotechnology, 2010
- ChIP-Seq identification of weakly conserved heart enhancersNature Genetics, 2010
- A Global In Vivo Drosophila RNAi Screen Identifies NOT3 as a Conserved Regulator of Heart FunctionCell, 2010
- BEDTools: a flexible suite of utilities for comparing genomic featuresBioinformatics, 2010
- Predictive chromatin signatures in the mammalian genomeHuman Molecular Genetics, 2009
- Many ribosomal protein mutations are associated with growth impairment and tumor predisposition in zebrafishDevelopmental Dynamics, 2008
- Tbx5-dependent pathway regulating diastolic function in congenital heart diseaseProceedings of the National Academy of Sciences, 2008
- Cytoscape: A Software Environment for Integrated Models of Biomolecular Interaction NetworksGenome Research, 2003